Epoprostenol sodium, commonly known by its brand name Flolan or Veletri, is a potent vasodilator used primarily in the treatment of
pulmonary arterial hypertension (PAH). While it can be life-saving for patients with severe forms of PAH, it is crucial to be aware of its potential side effects. Understanding these side effects can help patients and caregivers monitor and manage any adverse reactions more effectively.
One of the most common side effects of epoprostenol sodium is
headache. Many patients report experiencing mild to severe headaches shortly after starting the treatment. These headaches can often be managed with over-the-counter
pain medications, but should be discussed with a healthcare provider if they become severe or persistent.
Nausea and
vomiting are other frequently observed side effects. These gastrointestinal symptoms can be quite distressing and may affect the patient's ability to maintain a proper diet. Anti-nausea medications can sometimes help alleviate these symptoms, but ongoing issues should be reported to a healthcare professional.
Flushing, or a feeling of warmth and redness particularly in the face, neck, and upper chest, is another common side effect. This occurs because epoprostenol sodium causes blood vessels to dilate, improving blood flow but sometimes leading to this uncomfortable sensation. Usually, this side effect is temporary and diminishes as the body adjusts to the medication.
Patients may also experience
dizziness and lightheadedness. These symptoms are particularly common when a patient first starts taking the medication or when the dosage is adjusted. To minimize the risk of dizziness, patients are advised to stand up slowly from sitting or lying positions and to avoid driving or operating heavy machinery until they know how the medication affects them.
Diarrhea is a less common but still noteworthy side effect. The occurrence of diarrhea can be troublesome and may lead to
dehydration if not properly managed. Increasing fluid intake and adjusting dietary habits can often help mitigate this issue.
Epoprostenol sodium is administered via continuous intravenous infusion, which means that complications related to the infusion site are possible. These can include pain,
redness,
swelling, or
infection at the infusion site. Proper care and hygiene can minimize these risks, but any signs of infection should be reported to a healthcare provider immediately.
One serious but rare side effect is an increased risk of
bleeding. Epoprostenol sodium inhibits platelet aggregation, which can lead to an increased tendency to bleed. Patients should be aware of signs of unusual bleeding, such as
nosebleeds,
bleeding gums, or blood in the urine or stool, and report them to their healthcare provider.
Hypotension, or low blood pressure, is another potential risk. Because epoprostenol sodium is a vasodilator, it can sometimes lower blood pressure too much, leading to symptoms like
fainting, severe dizziness, or even
shock in extreme cases. Regular monitoring of blood pressure is essential for anyone taking this medication.
In some cases, patients may develop
jaw pain, particularly when chewing food. This side effect is generally mild but can be persistent. If jaw pain becomes problematic, it should be discussed with a healthcare provider.
Lastly, it is important to note that not all patients will experience these side effects, and some may experience side effects not listed here. It is vital to maintain open communication with healthcare providers to ensure that any adverse reactions are promptly addressed. Regular follow-up appointments and monitoring can help manage side effects effectively, allowing patients to gain the maximum benefit from their treatment with epoprostenol sodium.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


